INDIANAPOLIS, Oct. 7, 2010 (GLOBE NEWSWIRE) -- Positron Corporation (OTCBB:POSC), a leading molecular imaging company specializing in the field of nuclear cardiology, commented on the new medical ...

The evaluation of radiation dose in positron emission tomography (PET) is an essential component of modern nuclear medicine. Accurate dosimetric assessment ensures that the diagnostic benefits of PET ...

LOS ALAMOS, N.M., July 29, 2020--A multi-institution team has used positron beams to probe the nature of radiation effects, providing new insight into how damage is produced in iron films. This ...

A team of researchers from North Carolina State University, the University of Michigan and Oak Ridge National Laboratory have constructed a low-energy positron beam at NC State's PULSTAR nuclear ...

Advances in the technology for detecting radiation emitted by radioisotopes have presented new opportunities in the diagnosis and, potentially, screening for breast cancer. Positron emission ...

Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic ...

Niagara Falls, NY, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced the sale of ...

Niagara Falls, NY, April 14, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging medical device company specializing in PET and PET-CT ...